Trial intelligence / Profile preview

ZuraPrep Antimicrobial Effectiveness Pilot

NCT02221232Phase 2Terminated

Sponsor
Zurex Pharma
Start
Aug 2014
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ChloraPrep in surgical site infection (SSI), sponsored by Zurex Pharma. Started Aug 2014; status: terminated.

02

Drugs

ChloraPrep
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02221232.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02221232.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call